Goldline Pharmaceutical IPO Details

SME

Goldline Pharmaceutical IPO DRHP (Draft Red Herring Prospectus) has been Filed with Exchange.

Goldline Pharmaceutical IPO total issue size comprises 30,00,000 shares (aggregating up to ₹0.00 Cr.). This includes a fresh issue of 30,00,000 shares (aggregating up to ₹0.00 Cr.). Pre-issue shareholding stands at 69,00,000, which will increase to 99,00,000 post-issue.

The Lead Managers for Goldline Pharmaceutical IPO are crucial for the offering's success. They are responsible for a wide range of tasks, including preparing the company for the public market, managing the regulatory filings, and marketing the IPO to potential investors. The lead manager for this offering is Cumulative Capital Private Limited. To assess their past performance and success in previous IPOs, you can view the Lead Manager Performance Summary report.

For detailed information, Refer to the Goldline Pharmaceutical Limited DRHP.

Goldline Pharmaceutical IPO Details

Open Date
-
Close Date
-
Listing Date
-
Issue Price
₹0 - ₹0
Face Value
₹10 per share
Lot Size
0
GMP
₹0
Issue Type
IPO
Listing On
BSE
Type
Book Built Issue
Share holding pre issue
6900000
Share holding post issue
9900000
Total Issue Size
30,00,000 shares (aggregating up to ₹0.00 Cr.)
Fresh Issue
30,00,000 shares (aggregating up to ₹0.00 Cr.)
Offer for Sale
-
DRHP Status
Filed with Exchange

Goldline Pharmaceutical IPO Lot Size

ApplicationLotsSharesAmount
To be announced

Goldline Pharmaceutical IPO Reservation

Promoter Holding

Pre Issue:79.70%
Post Issue:-
Promoter Names:
Amol Laxmikant Mujumdar, Swapan Premprakash Khandelwal

Documents

  ›  Goldline Pharmaceutical IPO DRHP

Goldline Pharmaceutical IPO Valuations

ROE:35.84%
ROCE:38.46%
DEBT/EQUITY:1.50
RONW:27.38%
PAT MARGIN:10.10%

Goldline Pharmaceutical Financial Information

Period Ended31 Mar 202531 Mar 202431 Mar 2023
Assets26.2822.9319.39
Total Income28.0623.5719.85
Profit After Tax2.831.810.26
EBITDA5.834.302.19
NET Worth10.357.875.89
Reserves and Surplus1.653.762.08
Total Borrowing11.0311.1310.83
Amount in ₹ Crore

About Goldline Pharmaceutical IPO

Goldline Pharmaceuticals is engaged in the business of marketing pharmaceutical products under the brand name “Goldline.” Its product range is divided into five segments:

  1. Goldline Pharma: This category includes 42 products to cater to specialties like Physicians, Orthopedics, ENT, Chest Physicians, General and Specialty Surgery, Gastroenterology, Neurology, and Urology.
  2. Goldline Cardinal: This category offers 54 products tailored for the Specialty division, serving medical fields such as Physicians, Diabetologists, Endocrinologists, Cardiologists, and General Physicians.
  3. Goldline Aayushman: This category comprises 18 products designed for the Specialty division, catering to medical fields such as Pediatricians, Child Specialists, Neonatologists, and General Practitioners.
  4. Goldline InLife: This category includes 22 products tailored for the Specialty division, serving Intensivists, Critical Care Consultants, Super Specialty Surgeons, and Physicians.
  5. Goldline Wellness: This category includes 10 products tailored Supportive care plays a crucial role in cancer therapy.

The company do not manufacture products, it partner with third-party manufacturers who produce the medicines based on its market research and product specifications, ensuring quality and compliance with regulations.

All products are marketed and sold under the Goldline brand through our network of distributors, who supply to retailers and wholesalers. The company currently works with 15 manufacturers and 7 distributors, and it also support hospitals and healthcare providers with procurement and material supply.

The company sells products across the states of Maharashtra, Madhya Pradesh, Odisha, Jharkhand, Tamil Nadu, Rajasthan, and Bihar.

Competitive Strengths:

  • Experienced Promoters and Management Team with Industry Knowledge and a Track Record
  • Asset-light Business Model and Competitive Products
  • Scalable Business Model
  • Wide and Diverse Range of Product Offerings
  • Strong Supplier and Vendor Relationships
  • Established Distribution Network

Strength Of Goldline Pharmaceutical IPO

To be announced

Risk Of Goldline Pharmaceutical IPO

To be announced

Objectives Goldline Pharmaceutical IPO

1. Prepayment or repayment of all or a portion of certain outstanding borrowings availed by our company

2. General corporate purposes

Company Contact Details

Goldline Pharmaceutical Ltd.
103, F-1, Leela Apartment, Shilpa HSG Society,
Near Saptagiri Nagar, Shanidham,
Narendra Nagar,
Nagpur, Maharashtra, 440015
Phone: +91 712 2786666
Email: info@goldlinepharma.in
Website: http://www.goldlinepharma.in/

Registrar Contact Details

Name: Bigshare Services Pvt Ltd
Phone: +91-22-62638200
Website: https://ipo.bigshareonline.com/ipo_status.html

Lead Mangers

  1. Cumulative Capital Private Limited

    (Past IPO Performance)

Lead Manager Reports

Market Maker

To be announced

Read more about Goldline Pharmaceutical Limited IPO

Comments

© Copyright A2ZIPO. All Rights Reserved
A2ZIPOA2ZIPO